Showing results (41-50 of 1,875) with videos related to

Sort By:
Pageof 188
Therapeutic Advances in Medical Oncology|July 21, 2022
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancerValentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, et al.
Therapeutic Advances in Medical Oncology|July 25, 2022
Tumor vessel normalization and immunotherapy in gastric cancerXianzhe Yu, Shan He, Jian Shen, et al.
Therapeutic Advances in Medical Oncology|July 20, 2019
The endonuclease APE1 processes miR-92b formation, thereby regulating expression of the tumor suppressor LDLR in cervical cancer cellsYi Sun, Yun Feng, Guiqian Zhang, et al.
Therapeutic Advances in Medical Oncology|September 20, 2019
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysisAntonio Galvano, Simona Taverna, Giuseppe Badalamenti, et al.
Therapeutic Advances in Medical Oncology|March 6, 2019
Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysisSusu Han, Tao Huang, Xing Wu, et al.
Therapeutic Advances in Medical Oncology|January 25, 2021
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancerPernelle Lavaud, Clément Dumont, Constance Thibault, et al.
Therapeutic Advances in Medical Oncology|January 25, 2021
Safety and efficacy of extended dosing intervals of denosumab in patients with solid cancers and bone metastases: a retrospective studyAseala I Abousaud, Meagan S Barbee, Christine C Davis, et al.
Therapeutic Advances in Medical Oncology|January 25, 2021
Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approachWen Feng, Yuan Li, Lei Shen, et al.
Therapeutic Advances in Medical Oncology|February 26, 2021
Ocular adverse events associated with immune checkpoint inhibitors: a novel multidisciplinary management algorithmOrthi Shahzad, Nicola Thompson, Gerry Clare, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancerAndrea Rocca, Pietro Cortesi, Laura Cortesi, et al.
Pageof 188